Table 5. Relative hazard of death following the receipt of acute care interventions by stroke subtype and GCS.

	Subtype, HR (95% CI)			GCS, HR (95% CI)
	Infarction	PICH	p-value**	<9	9–12	13–15	p-value**
Stroke unit admission	0.74(0.62–0.89)	0.39(0.27–0.57)	0.0052	0.44(0.33–0.58)	0.48(0.33–0.70)	0.98(0.78–1.23)	0.0238
50% of stay on a stroke unit	0.79(0.66–0.96)	0.56(0.37–0.86)	0.0875	0.60(0.45–0.81)	0.73(0.49–1.07)	0.93(0.72–1.22)	0.8396
50% of stay on a stroke unit*	1.05(0.78–1.41)	1.35(0.68–2.68)	0.8410	1.27(0.75–2.17)	1.52(0.85–2.69)	0.77(0.51–1.15)	0.3486
Brian imaging	0.43(0.30–0.62)	0.47(0.14–1.58)	0.2520	0.37(0.23–0.62)	0.49(0.19–1.30)	0.90(0.48–1.66)	0.2929
Swallow test done	0.78(0.57–1.07)	0.68(0.41–1.12)	0.1014	0.66(0.45–0.96)	0.38(0.21–0.71)	1.17(0.73–1.87)	0.0134
Aspirin given inthe acute phase	NA	NA	NA	0.33(0.18–0.61)	0.29(0.12–0.67)	0.77(0.43–1.36)	0.0007
PTOT	0.47(0.32–0.68)	0.07(0.03–0.22)	<0.0001	0.13(0.07–0.24)	0.20(0.09–0.46)	0.83(0.40–1.71)	<0.001
PTOT*	0.46(0.27–0.80)	0.04(0.01–0.22)	0.0041	0.10(0.04–0.23)	0.16(0.04–0.73)	0.85(0.36–2.01)	0.0005
SALT	0.45(0.32–0.64)	0.21(0.09–0.45)	0.0141	0.15(0.09–0.26)	0.12(0.05–0.29)	1.38(0.76–2.48)	<0.001
SALT*	0.52(0.34–0.81)	0.26(0.09–0.76)	0.2736	0.11(0.05–0.25)	0.21(0.05–0.95)	1.32(0.70–2.48)	<0.001

^*excluding patients not admitted to a su.

^**P<0.005 considered statistically significant.

NA not applicable.